Antiphospholipids and pregnancy--a review

Area of Science:

• Immunology
• Hematology
• Obstetrics & Gynecology

Background:

• Antiphospholipid antibodies are linked to a syndrome involving low platelets, blood clots, and pregnancy loss.
• The exact cause of this autoimmune response remains unclear.
• This condition results in abnormal platelet aggregation and thrombosis.

Purpose of the Study:

• To summarize the clinical characteristics and management of antiphospholipid antibody syndrome.

Main Methods:

• Review of existing literature on antiphospholipid antibody syndrome.
• Description of clinical manifestations including thrombocytopenia, thrombosis, and fetal loss.
• Outline of standard treatment protocols.

Main Results:

• The syndrome is characterized by recurrent arterial and venous thromboses.
• Recurrent fetal loss is a significant clinical feature.
• Thrombocytopenia is commonly observed in affected individuals.

Conclusions:

• Antiphospholipid antibody syndrome is an autoimmune disorder with serious thrombotic and obstetric complications.
• Current management focuses on anticoagulation and antiplatelet therapy.
• Low-dose aspirin, heparin, and corticosteroids are the primary treatments.